SonarPore selected for 1stRound non-equity support
The blood-testing research team joins the programme’s 15th cohort.
SonarPore was named among the eight teams selected for the 15th 1stRound programme on 5 October 2026. The programme provides non-equity funding and hands-on support; SonarPore’s individual allocation was not disclosed.
The University of Tokyo research spinout, led by Hiroaki Kaneko, was preparing for incorporation when the cohort was announced. Its work targets the difficult distinction between cancer-related changes and inflammation in blood samples.
Use of funds
Single-molecule blood testing research and startup formation support